The role of the lymphatic system in inflammatory-erosive arthritis

Seminars in Cell and Developmental Biology

Volumn 38, Issue , 2015, Pages 90-97

  Bouta, Echoe M ^a   Li, Jie ^a   Ju, Yawen ^a   Brown, Edward B ^a   Ritchlin, Christopher T ^a   Xing, Lianping ^a   Schwarz, Edward M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Flare; Lymph node; Lymphatic vessel; Rheumatoid arthritis

Indexed keywords

BIOLOGICAL MARKER; VASCULOTROPIN C;

ASYMPTOMATIC DISEASE; B LYMPHOCYTE; CONNECTIVE TISSUE; CONTRAST ENHANCEMENT; DISEASE EXACERBATION; KNEE ARTHRITIS; LYMPH FLOW; LYMPH FOLLICLE; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; NONHUMAN; OSTEOCLAST; POPLITEAL LYMPH NODE; REVIEW; RHEUMATOID ARTHRITIS; SYNOVITIS; ANIMAL; HUMAN; IMMUNOLOGY; LYMPH NODE; PATHOLOGY; PHYSIOLOGY; RECURRENT DISEASE;

MURINAE;

ANIMALS; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; HUMANS; LYMPH NODES; LYMPHATIC SYSTEM; SYMPTOM FLARE UP;

EID: 84928209369     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2015.01.001     Document Type: Review

References (58)

1. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
2. Nishimura K., Sugiyama D., Kogata Y., Tsuji G., Nakazawa T., Kawano S., et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007, 146:797-808.
3. Feldmann M., Maini S.R. Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol Rev 2008, 223:7-19.
4. Kuek A., Hazleman B.L., Ostor A.J. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J 2007, 83:251-260.
5. Nielen M.M., van Schaardenburg D., Reesink H.W., van de Stadt R.J., van der Horst-Bruinsma I.E., de Koning M.H., et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50:380-386.
6. Silman A.J., Newman J., MacGregor A.J. Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins. Arthritis Rheum 1996, 39:732-735.
7. Mahdi H., Fisher B.A., Kallberg H., Plant D., Malmstrom V., Ronnelid J., et al. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet 2009, 41:1319-1324.
8. McGonagle D., Ash Z.R., Hodgson R.J., Emery P., Radjenovic A. MRI for the assessment and monitoring of RA - what can it tell us?. Nat Rev Rheumatol 2011, 7:185-189.
9. Smolen J.S., Aletaha D., Bijlsma J.W., Breedveld F.C., Boumpas D., Burmester G., et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010, 69:631-637.
10. Quinn M.A., Emery P. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. Clin Exp Rheumatol 2003, 21:S154-S157.
11. Paavonen K., Mandelin J., Partanen T., Jussila L., Li T.F., Ristimaki A., et al. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium. J Rheumatol 2002, 29:39-45.
12. Wauke K., Nagashima M., Ishiwata T., Asano G., Yoshino S. Expression and localization of vascular endothelial growth factor-C in rheumatoid arthritis synovial tissue. J Rheumatol 2002, 29:34-38.
13. Huh Y.M., Kim S., Suh J.S., Song H., Song K., Shin K.H. The role of popliteal lymph nodes in differentiating rheumatoid arthritis from osteoarthritis by using CE 3D FSPGR MR imaging: relationship of the inflamed synovial volume. Korean J Radiol 2005, 6:117-124.
14. Grillet B., Dequeker J. Rheumatoid lymphedema. J Rheumatol 1987, 14:1095-1097.
15. Jayson M.I., Cavill I., Barks J.S. Lymphatic clearance rates in rheumatoid arthritis. Ann Rheum Dis 1971, 30:638-639.
16. Olszewski W.L., Pazdur J., Kubasiewicz E., Zaleska M., Cooke C.J., Miller N.E. Lymph draining from foot joints in rheumatoid arthritis provides insight into local cytokine and chemokine production and transport to lymph nodes. Arthritis Rheum 2001, 44:541-549.
17. Polzer K., Baeten D., Soleiman A., Distler J., Gerlag D.M., Tak P.P., et al. Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints. Ann Rheum Dis 2008, 67:1610-1616.
18. Keffer J., Probert L., Cazlaris H., Georgopoulos S., Kaslaris E., Kioussis D., et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991, 10:4025-4031.
19. Kouskoff V., Korganow A.S., Duchatelle V., Degott C., Benoist C., Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell 1996, 87:811-822.
20. Ritchlin C.T., Haas-Smith S.A., Li P., Hicks D.G., Schwarz E.M. Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 2003, 111:821-831.
21. Li P., Schwarz E.M., O'Keefe R.J., Ma L., Looney R.J., Ritchlin C.T., et al. Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice. Arthritis Rheum 2004, 50:265-276.
22. Zhang Q., Guo R., Lu Y., Zhao L., Zhou Q., Schwarz E.M., et al. VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism. J Biol Chem 2008, 283:13491-13499.
23. Zhang Q., Lu Y., Proulx S., Guo R., Yao Z., Schwarz E.M., et al. Increased lymphangiogenesis in joints of mice with inflammatory arthritis. Arthritis Res Ther 2007, 9:R118.
24. van den Berg W.B. Animal models of arthritis. What have we learned?. J Rheumatol Suppl 2005, 72:7-9.
25. Proulx S.T., Kwok E., You Z., Papuga M.O., Beck C.A., Shealy D.J., et al. Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography. Arthritis Rheum 2007, 56:4024-4037.
26. Proulx S.T., Kwok E., You Z., Beck C.A., Shealy D.J., Ritchlin C.T., et al. MRI and quantification of draining lymph node function in inflammatory arthritis. Ann N Y Acad Sci 2007, 1117:106-123.
27. Guo R., Zhou Q., Proulx S.T., Wood R., Ji R.C., Ritchlin C.T., et al. Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis. Arthritis Rheum 2009, 60:2666-2676.
28. Zhou Q., Wood R., Schwarz E.M., Wang Y.J., Xing L. Near-infrared lymphatic imaging demonstrates the dynamics of lymph flow and lymphangiogenesis during the acute versus chronic phases of arthritis in mice. Arthritis Rheum 2010, 62:1881-1889.
29. Zhou Q., Guo R., Wood R., Boyce B.F., Liang Q., Wang Y.J., et al. Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice. Arthritis Rheum 2011, 63:2318-2328.
30. Li J., Kuzin I., Moshkani S., Proulx S.T., Xing L., Skrombolas D., et al. Expanded CD23(+)/CD21(hi) B cells in inflamed lymph nodes are associated with the onset of inflammatory-erosive arthritis in TNF-transgenic mice and are targets of anti-CD20 therapy. J Immunol 2010, 184:6142-6150.
31. Li J., Ju Y., Bouta E.M., Xing L., Wood R.W., Kuzin I., et al. Efficacy of B cell depletion therapy for murine joint arthritis flare is associated with increased lymphatic flow. Arthritis Rheum 2013, 65:130-138.
32. Li J., Zhou Q., Wood R., Kuzin I., Bottaro A., Ritchlin C.T., et al. CD23+/CD21hi B cell translocation and ipsilateral lymph node collapse is associated with asymmetric arthritic flare in TNF-Tg mice. Arthritis Res Ther 2011, 13:R138.
33. Binder N.B., Puchner A., Niederreiter B., Hayer S., Leiss H., Bluml S., et al. Tumor necrosis factor-inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor-driven model of rheumatoid arthritis. Arthritis Rheum 2013, 65:608-617.
34. Moshkani S., Kuzin I.I., Adewale F., Jansson J., Sanz I., Schwarz E.M., et al. CD23+ CD21(high) CD1d(high) B cells in inflamed lymph nodes are a locally differentiated population with increased antigen capture and activation potential. J Immunol 2012, 188:5944-5953.
35. Li J., Zhou Q., Wood R., Kuzin I., Bottaro A., Ritchlin C., et al. CD23+/CD21hi B cell translocation and ipsilateral lymph node collapse is associated with asymmetric arthritic flare in TNF-Tg mice. Arthritis Res Ther 2011, 13:R138.
36. Weinblatt M.E., Keystone E.C., Furst D.E., Moreland L.W., Weisman M.H., Birbara C.A., et al. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 2003, 48:35-45.
37. Weinblatt M.E., Kremer J.M., Bankhurst A.D., Bulpitt K.J., Fleischmann R.M., Fox R.I., et al. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999, 340:253-259.
38. Cohen S.B., Emery P., Greenwald M.W., Dougados M., Furie R.A., Genovese M.C., et al. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 2006, 54:2793-2806.
39. Leandro M.J., de la Torre I. Translational mini-review series on B cell-directed therapies: the pathogenic role of B cells in autoantibody-associated autoimmune diseases - lessons from B cell-depletion therapy. Clin Exp Immunol 2009, 157:191-197.
40. Galli S.J., Borregaard N., Wynn T.A. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 2011, 12:1035-1044.
41. Manzo A., Caporali R., Vitolo B., Alessi S., Benaglio F., Todoerti M., et al. Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography. Rheumatology (Oxford) 2011, 50:1395-1400.
42. Ju Y., Rahimi H., Li J., Wood R.W., Xing L., Schwarz E.M. Validation of 3-dimensional ultrasound versus magnetic resonance imaging quantification of popliteal lymph node volume as a biomarker of erosive inflammatory arthritis in mice. Arthritis Rheum 2012, 64:2048-2050.
43. Bouta E.M., Ju Y., Rahimi H., de Mesy-Bentley K.L., Wood R.W., Xing L., et al. Power Doppler ultrasound phenotyping of expanding versus collapsed popliteal lymph nodes in murine inflammatory arthritis. PLOS ONE 2013, 8:e73766.
44. Bouta E.M., Wood R.W., Perry S.W., Brown E.B., Ritchlin C.T., Xing L., et al. Measuring intranodal pressure and lymph viscosity to elucidate mechanisms of arthritic flare and therapeutic outcomes. Ann N Y Acad Sci 2011, 1240:47-52.
45. Bouta E.M., Wood R.W., Brown E.B., Rahimi H., Ritchlin C.T., Schwarz E.M. In vivo quantification of lymph viscosity and pressure in lymphatic vessels and draining lymph nodes of arthritic joints in mice. J Physiol 2014, 592:1213-1223.
46. Sullivan K.D., Sipprell W.H., Brown E.B., Brown E.B. Improved model of fluorescence recovery expands the application of multiphoton fluorescence recovery after photobleaching in vivo. Biophys J 2009, 96:5082-5094.
47. Schmid-Schonbein G.W. Nitric oxide (NO) side of lymphatic flow and immune surveillance. Proc Natl Acad Sci U S A 2012, 109:3-4.
48. Liao S., Cheng G., Conner D.A., Huang Y., Kucherlapati R.S., Munn L.L., et al. Impaired lymphatic contraction associated with immunosuppression. Proc Natl Acad Sci U S A 2011, 108:18784-18789.
49. Mathias R., von der Weid P.Y. Involvement of the NO-cGMP-K(ATP) channel pathway in the mesenteric lymphatic pump dysfunction observed in the guinea pig model of TNBS-induced ileitis. Am J Physiol Gastrointest Liver Physiol 2013, 304:G623-G634.
50. Padera T.P., Kadambi A., di Tomaso E., Carreira C.M., Brown E.B., Boucher Y., et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science (New York, NY) 2002, 296:1883-1886.
51. Hoshida T., Isaka N., Hagendoorn J., di Tomaso E., Chen Y.L., Pytowski B., et al. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res 2006, 66:8065-8075.
52. Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P., et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001, 7:192-198.
53. Wu T.F., Carati C.J., Macnaughton W.K., von der Weid P.Y. Contractile activity of lymphatic vessels is altered in the TNBS model of guinea pig ileitis. Am J Physiol Gastrointest Liver Physiol 2006, 291:G566-G574.
54. Hos D., Cursiefen C. Lymphatic vessels in the development of tissue and organ rejection. Adv Anat Embryol Cell Biol 2014, 214:119-141.
55. Martel C., Li W., Fulp B., Platt A.M., Gautier E.L., Westerterp M., et al. Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J Clin Invest 2013, 123:1571-1579.
56. Lim H.Y., Rutkowski J.M., Helft J., Reddy S.T., Swartz M.A., Randolph G.J., et al. Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration. Am J Pathol 2009, 175:1328-1337.
57. Machnik A., Neuhofer W., Jantsch J., Dahlmann A., Tammela T., Machura K., et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 2009, 15:545-552.
58. Rasmussen J.C., Tan I.C., Marshall M.V., Adams K.E., Kwon S., Fife C.E., et al. Human lymphatic architecture and dynamic transport imaged using near-infrared fluorescence. Transl Oncol 2010, 3:362-372.